Health Care Spending Associated With Preventative Pharmacologic Therapy for Urolithiasis
Among patients with hypocitraturia and low pH, adherence was the most expensive, driven by medication costs. Conversely, among patients with hypercalciuria and hyperuricosuria, nonadherence was costliest. Although PPT can lead to reduced costs due to averted stone events, medication adherence is critical to ensuring these savings are fully realized.
Authors
- Ryan S. Hsi (ORCID: https://orcid.org/0000-0003-1652-694X)
- Sara L. Best (ORCID: https://orcid.org/0000-0001-7285-2833)
- Wilson Sui (ORCID: https://orcid.org/0000-0002-1819-6596)
- Joseph J. Crivelli (ORCID: https://orcid.org/0000-0001-6140-279X)
- Vahakn B. Shahinian (ORCID: https://orcid.org/0000-0003-3280-7821)
- Mary Oerline (ORCID: https://orcid.org/0000-0002-0264-6951)
- John M. Hollingsworth (ORCID: https://orcid.org/0000-0002-3372-9370)
Institutions
- Bank of America (US)
- University of Wisconsin–Madison (US)
- University of Michigan (US)
- LabCorp (United States) (US)
- University of Alabama at Birmingham (US)
- University of Florida (US)
- Birmingham VA Medical Center (US)
- Link Foundation (US)
- Vanderbilt University Medical Center (US)
- Florida College (US)
Publication Details
- Journal
- Urology Practice
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1097/upj.0000000000000829
- Primary Topic
- Kidney Stones and Urolithiasis Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00